Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers

BACKGROUND: Dronabinol, a pharmaceutical Δ-9-tetrahydrocannabinol, was originally developed as an oral capsule. This study evaluated the bioavailability of a new formulation, dronabinol oral solution, versus a dronabinol capsule formulation. METHODS: In an open-label, four-period, single-dose, cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Neha, Kramer, William G, Khurana, Varun, Cognata Smith, Christina, Vetticaden, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066862/
https://www.ncbi.nlm.nih.gov/pubmed/27785111
http://dx.doi.org/10.2147/CPAA.S115679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066862/
https://www.ncbi.nlm.nih.gov/pubmed/27785111
http://dx.doi.org/10.2147/CPAA.S115679

Ejemplares similares